Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside.

Patel, Shivangi; Sharma, Dilip; Uniyal, Ankit; Gadepalli, Anagha; Tiwari, Vinod

Patel, Shivangi; Sharma, Dilip; Uniyal, Ankit; Gadepalli, Anagha; Tiwari, Vinod.

Afiliación

Patel S; Department of Pharmacology, Bombay College of Pharmacy, 400098, Mumbai, India.
Sharma D; Rutgers New Jersey Medical School, 07103, Newark, NJ, United States.
Uniyal A; Department of Pharmaceutical Engineering, Indian Institute of Technology (Banaras Hindu University), 221005, Varanasi, U.P, India.
Akhilesh; Department of Pharmaceutical Engineering, Indian Institute of Technology (Banaras Hindu University), 221005, Varanasi, U.P, India.
Gadepalli A; Department of Pharmaceutical Engineering, Indian Institute of Technology (Banaras Hindu University), 221005, Varanasi, U.P, India.
Tiwari V; Department of Pharmaceutical Engineering, Indian Institute of Technology (Banaras Hindu University), 221005, Varanasi, U.P, India. vtiwari.phe@iitbhu.ac.in.

Metab Brain Dis ; 37(7): 2197-2211, 2022 10.

Article en En | MEDLINE | ID: mdl-35239143

Asunto(s)

Esquizofrenia; Humanos; Esquizofrenia/tratamiento farmacológico; Biomarcadores/metabolismo; Pronóstico; Neurotransmisores

Palabras clave

Biomarkers; Cognition; Negative symptoms; Neurodegeneration; Neuroinflammation; Schizophrenia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Metab Brain Dis Asunto de la revista: CEREBRO / METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google